Loading…
iHuman Inc. is projected to rise to $1.87 by 2027, a +31% move from its current price of $1.42. IH is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.38 | $1.42 | $1.46 | +0.08% |
| Jul 14 | $1.37 | $1.42 | $1.48 | +0.16% |
| Jul 15 | $1.36 | $1.42 | $1.49 | +0.24% |
| Jul 16 | $1.35 | $1.42 | $1.51 | +0.32% |
| Jul 17 | $1.34 | $1.43 | $1.52 | +0.41% |
| Jul 18 | $1.33 | $1.43 | $1.53 | +0.49% |
| Jul 19 | $1.33 | $1.43 | $1.54 | +0.57% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.33 | $1.43 | $1.54 | +0.57% |
| Week 2 | $1.29 | $1.44 | $1.60 | +1.14% |
| Week 3 | $1.27 | $1.44 | $1.64 | +1.72% |
| Week 4 | $1.25 | $1.45 | $1.69 | +2.29% |
| Week 5 | $1.24 | $1.46 | $1.73 | +2.88% |
| Week 6 | $1.22 | $1.47 | $1.76 | +3.46% |
| Week 7 | $1.21 | $1.48 | $1.80 | +4.05% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
iHuman Inc., together with its subsidiaries, provides an integrated suite of tech-powered intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China.
The company offers interactive and self-directed apps, including iHuman Chinese, iHuman English, iHuman Pinyin, iHuman Math, iHuman Books, iHuman Stories, iHuman Chinese Classics, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Readers, iHuman Writing, iHuman Fantastic Friends, iHuman AI Coding, and FreeTalk; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, bekids Library, and the Gogo series; Reading Stars; and Aha World and Aha Makeover. It also provides offline products, such as iHuman AI Pal, a plush AI companion; and the iHuman AI Bilingual Early Learning Tablet, an AI-powered smart learning tablet that delivers a bilingual Chinese-English content library for children. In addition, the company offers intellectually stimulating materials, including books, interactive materials, and smart devices that develop children's abilities in speaking, critical thinking, independent reading, and creativity.
Further, it engages in the operation of online applications; provision of management and technical consulting; and research and development activities. iHuman Inc. was founded in 1996 and is based in Beijing, the People's Republic of China.
IH is currently priced at $1.43 with a market cap of $72.94M and a rank of 4399. This places IH among small-cap names within the Consumer Defensive category. The near-term setup shows a neutral technical backdrop, while the long-run forecast points to clear upside, with the average price rising across years and meaningful ROIs in the outer years.
The near-term picture is informed by a neutral sentiment, with RSI(14) at 50 and key moving averages around the current price: SMA50 at $1.55 and SMA200 at $2.05. Immediate support sits at $1.35 and resistance at $1.78, with the 30-day trading range between $1.18 and $1.73.
A major floor 23.5% below — a decisive break under it would weaken the trend.
The nearest floor, 4.9% below — buyers have tended to step in here.
The nearest ceiling, 25.4% above — a clean break opens room to run.
A major ceiling 40.8% above — clearing it would confirm fresh momentum.
Key IH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.44 | Sell | $1.43 | Sell |
| MA 10 | $1.42 | Sell | $1.42 | Sell |
| MA 20 | $1.40 | Buy | $1.44 | Sell |
| MA 50 | $1.54 | Sell | $1.53 | Sell |
| MA 100 | $1.66 | Sell | $1.67 | Sell |
| MA 200 | $2.05 | Sell | $1.89 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.23 | Neutral |
| Stoch RSI (14) | 70.21 | Neutral |
| CCI (20) | 46.68 | Neutral |
| Williams %R (14) | -48.98 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 1.79 | Buy |
| Bollinger %B (20,2) | 0.63 | Neutral |
| Stochastic %K (14) | 51.02 | Neutral |
| TRIX (15) | -0.45 | Sell |
| Awesome (5,34) | -0.04 | Sell |
| Ultimate (7,14,28) | 52.27 | Neutral |
| Momentum (10) | 0.04 | Buy |
| Aroon Osc (25) | -16.00 | Sell |
| Hull MA (9) | 1.44 | Sell |
| ADX (14) | 13.85 | Neutral |
| ATR (14) | 0.04 | Info |
The 30-day technical picture remains NEUTRAL. RSI(14) is 50, indicating no clear momentum tilt. The 50-day moving average sits near the price at $1.55, while the 200-day moving average is higher at $2.05, suggesting potential resistance nearby.
Near-term support is pegged at $1.35, with resistance at $1.78. The 30-day trading range runs from $1.18 to $1.73, outlining a narrow band for the stock’s movement in the coming weeks.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.35 | $1.42 | $2.11 | 0% | Neutral | |
| $1.48 | $1.87 | $2.49 | +31% | Bullish | |
| $1.66 | $2.16 | $2.99 | +52% | Bullish | |
| $1.72 | $2.28 | $3.26 | +61% | Bullish | |
| $1.63 | $2.21 | $3.24 | +56% | Bullish | |
| $1.74 | $2.40 | $3.59 | +69% | Bullish | |
| $1.74 | $2.45 | $3.74 | +73% | Bullish | |
| $2.04 | $2.92 | $4.53 | +105% | Bullish | |
| $2.47 | $3.60 | $5.68 | +153% | Bullish | |
| $2.35 | $3.47 | $5.55 | +144% | Bullish | |
| $3.19 | $5.05 | $8.62 | +256% | Bullish | |
| $4.81 | $8.60 | $16.07 | +505% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.35 | $1.42 | $1.76 | +0.00% |
| August 2026 | $1.29 | $1.52 | $1.85 | +7.38% |
| September 2026 | $1.29 | $1.53 | $1.88 | +0.27% |
| October 2026 | $1.33 | $1.59 | $1.98 | +4.27% |
| November 2026 | $1.40 | $1.68 | $2.10 | +5.33% |
| December 2026 | $1.39 | $1.68 | $2.11 | -0.08% |
Click any year to see its month-by-month IH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, IH could reach as high as $2.11, with a base case around $1.42 and support toward $1.35 — roughly 0% from $1.42. Price action looks broadly range-bound.
Expect IH to range from $1.48 to $2.49 through 2027. The $1.87 average target implies a +31% move from current prices. That is up +31% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The IH price prediction for 2028 points to an average of $2.16 (low $1.66, high $2.99) — a potential gain of +52% on today's $1.42. Momentum favours further upside here.
In 2029, IH is projected to trade between $1.72 and $3.26, averaging $2.28 — a potential gain of +61% from today's $1.42. That is up +6% on the projected 2028 average. Buyers look set to stay in control over this stretch.
iHuman Inc.'s 2030 outlook centres on $2.21, within a $1.63 to $3.24 range. That is -3% versus the projected 2029 average. That marks a +56% change versus current levels. Momentum favours further upside here.
By 2031, IH could reach as high as $3.59, with a base case around $2.40 and support toward $1.74 — roughly +69% from $1.42. Buyers look set to stay in control over this stretch.
Expect IH to range from $1.74 to $3.74 through 2032. The $2.45 average target implies a +73% move from current prices. That is up +2% on the projected 2031 average. Momentum favours further upside here.
The IH price prediction for 2033 points to an average of $2.92 (low $2.04, high $4.53) — a potential gain of +105% on today's $1.42. Buyers look set to stay in control over this stretch.
In 2034, IH is projected to trade between $2.47 and $5.68, averaging $3.60 — a potential gain of +153% from today's $1.42. That is up +23% on the projected 2033 average. Momentum favours further upside here.
iHuman Inc.'s 2035 outlook centres on $3.47, within a $2.35 to $5.55 range. That is -4% versus the projected 2034 average. That marks a +144% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, IH could reach as high as $8.62, with a base case around $5.05 and support toward $3.19 — roughly +256% from $1.42. Momentum favours further upside here.
Expect IH to range from $4.81 to $16.07 through 2050. The $8.60 average target implies a +505% move from current prices. That is up +70% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in IH today (≈ 704.225352 IH) could be worth
$6,054.28
+$5,054.28 (+505%) by 2050 · US Dollar
Based on the average projected IH price of $8.6 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IHwould be worth at today's price.
$1,000 invested in IH on Jul 10, 2025 (≈ 449.640292 IH) would be worth
$638.49
-$361.51 (-36.2%) today · 0.64× · US Dollar
Based on a IH entry price of $2.22 vs. today's $1.42.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.41 | $1,007.09 | +0.7% |
| 1 month ago | $1.48 | $959.46 | -4.1% |
| 3 months ago | $1.68 | $845.24 | -15.5% |
| 6 months ago | $1.96 | $724.49 | -27.6% |
| 1 year ago | $2.22 | $638.49 | -36.2% |
| All time (5.0y) ago | $10.74 | $132.22 | -86.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IH forecast.
Our base-case forecast reaches $2.80 around 2033.
Implied market cap at $2.80: $62.48M
The multi-year forecast shows a bullish trajectory after 2026, with rising average prices and positive ROIs as the years progress. For 2027 the avg price is projected at $1.89, with a 32.4 ROI and a bullish sentiment, followed by 2028 at $2.19 avg and a 53.3 ROI. By 2029, the avg is $2.31 with a 61.9 ROI, and 2030 shows an avg of $2.24 with a 56.7 ROI.
The forecast continues to rise through 2031 ($2.43 avg, 70.2 ROI) and 2032 ($2.48 avg, 73.6 ROI), and accelerates into 2033 ($2.96 avg, 107.8 ROI) and 2034 ($3.67 avg, 156.8 ROI). In 2035 the avg is $3.51 with a 145.9 ROI. Long-horizon projections extend to 2040 ($5.16 avg, 261.3 ROI) and 2050 ($8.71 avg, 510.3 ROI) with bullish sentiment.
Overall, the model indicates substantial upside over the long run, with the max forecast reaching $16.47 in 2050 and the min forecast at $4.79 in 2050. These are estimates, not guarantees, and depend on future market conditions and adherence to assumptions driving the projections.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $2.24 with a min of $1.64 and a max of $3.29, and a 56.7 ROI, with bullish sentiment.
Forecasts point to bullish sentiment from 2027 onward, with positive ROIs such as 32.4 (2027), 53.3 (2028), 61.9 (2029), 70.2 (2031), 73.6 (2032), 107.8 (2033), 156.8 (2034), 261.3 (2040), and 510.3 (2050). These are estimates, not guarantees.
Yes. The max forecast prices include $5.83 in 2034, $8.88 in 2040, and $16.47 in 2050.
The 30-day range is $1.18 to $1.73.
Current price is $1.43 and market cap is $72.94M.
iHuman Inc. Community Discussion
0Share your iHuman Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.